Search company, investor...
Fluo Labs company logo

Fluo Labs

fluolabs.care

Founded Year

2020

About Fluo Labs

Fluo Labs is a medical device company that uses light therapeutics and photobiomodulation to help alleviate the symptoms of hay fever. The company is developing a drug-free, rapid relief device that will improve the way people manage allergic rhinitis. It aims to help those who don’t want to or cannot take medication due to contraindications, pregnancy, heart or thyroid conditions, and job restrictions.

Headquarters Location

San Marcos, California,

United States

Missing: Fluo Labs's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Fluo Labs's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Fluo Labs

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Fluo Labs is included in 1 Expert Collection, including Conference Exhibitors.

C

Conference Exhibitors

5,302 items

Fluo Labs Patents

Fluo Labs has filed 1 patent.

The 3 most popular patent topics include:

  • Atomic physics
  • Electromagnetic radiation
  • Quantum mechanics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/19/2022

Application

Application Date

7/19/2022

Grant Date

Title

Related Topics

Status

Application

Latest Fluo Labs News

Fluo Labs Announces Partnership With a Leading Global Life Sciences Company

Aug 12, 2021

San Marcos, California, UNITED STATES SAN MARCOS, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Fluo Labs, Inc., a premarket clinical-stage medical device company in the process of creating a breakthrough medical device aimed at dramatically improving the way people manage Allergic Rhinitis (also referred to as seasonal allergies or hay fever), announced today that it has partnered with a leading global life sciences company. The partnership, which includes a financial component, will help Fluo Labs fulfill its mission to improve the quality of life for millions of allergy sufferers and bring its device to a global market. “Tackling the growing allergy problem is hard. There has been little innovation in the space in the last 20 years,” said Lawrence Johnson, CEO of Fluo Labs. “We are excited to be pioneering a new category in nasal allergy care that will allow millions to get relief from their allergy symptoms without having to use medication. This will be especially valuable for those who can't take common allergy medications because of medical conditions or contraindications. This partnership will help us accelerate our plans to bring innovation to the fast-growing respiratory care category.” Fluo Labs is developing a technology that uses photobiomodulation - a form of light therapy - to reduce inflammation in the nasal cavity and inhibit the release of histamines - effectively acting as a natural antihistamine. With successful proof-of-concept studies under its belt, the Company is now undertaking the final phase of its clinical and technical evaluation with a view to obtaining a De Novo grant from the FDA and CE Certification. Created by a team of experts in the fields of light therapeutics, antihistamines, and nasal steroids, the technology is the result of years of cutting-edge research, preclinical and clinical development. Fluo Labs already holds two patents and has three more pending. Fluo Labs is running a limited-time equity crowdfunding campaign on StartEngine. Funds received from the global partner and raised through the crowdfunding campaign will be used to complete product development and clinical evaluation with a view to obtaining an FDA De Novo grant and CE Certification. To invest, visit https://www.startengine.com/fluo . About Fluo Labs Fluo Labs Inc. is a premarket clinical-stage medical device company on a mission to improve the quality of life for millions of people who suffer from seasonal allergies. Fluo Labs’ founders have decades of industry experience in the development of cutting-edge, light-based medical devices and extensive experience in multiple pharma and biotech therapeutic areas including virology, rhinitis drug therapies, and light therapeutics. Its first product is being designed to allow people to temporarily relieve their symptoms of allergic rhinitis with a drug-free, over-the-counter remedy. The technology has won multiple awards including Gear Diary’s Best of CES 2021 Award, Techlicious’ Top Picks of CES 2021 Award, and Fluo Labs was a P&G Ventures 2021 CES Innovation Challenge finalist. To learn more, visit https://www.fluolabs.care/ . Contact:

Fluo Labs Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Fluo Labs Rank

Fluo Labs Frequently Asked Questions (FAQ)

  • When was Fluo Labs founded?

    Fluo Labs was founded in 2020.

  • Where is Fluo Labs's headquarters?

    Fluo Labs's headquarters is located at San Marcos.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.